Antibody Drug May Protect Nursing Home Residents, Staff From COVID - 19
Preliminary results of the study conducted by drug maker Eli Lilly have not been peer - reviewed or published
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Nursing, Pathology, Pharmacy, Pulmonology, Institutional, Source Type: news
More News: COVID-19 | Internal Medicine | Nurses | Nursing | Pathology | Respiratory Medicine | Study